UnitedHealth gains 5% after Q1 results 📊 while Jonhson&Johnson declines slightly

18:16 16 āđ€āļĄāļĐāļēāļĒāļ™ 2024

Today, two major US companies associated with the medical-insurance (UnitedHealth) and medical (Johnson&Johnson) markets reported financial results for Q1 2024. Both companies reported higher-than-expected earnings, but it was UnitedHealth's (UNH.US) report that came as the bigger positive surprise, while Johnson&Johnson's (JNJ.US) results suggest lower demand in the MedTech sector. Both companies are listed members of the Dow Jones Industrial Average (DIJA) index.

UnitedHealth with a positive surprise

Despite the February 2024 cyber-attack, the company expects to achieve its previously set annual sales targets, to which the market reacted optimistically. Shares are gaining more than 4% in the pre-market. Revenues rose almost 9% from $91.9bn in Q1 2023 to $99.8bn in Q1 2024. Adjusted earnings per share came in at US$6.91 against US$6.61 forecasts.

āđ€āļĢāļīāđˆāļĄāđ€āļ—āļĢāļ”āļ—āļąāļ™āļ—āļĩāļ§āļąāļ™āļ™āļĩāđ‰ āļŦāļĢāļ·āļ­ āļĨāļ­āļ‡āđƒāļŠāđ‰āļšāļąāļāļŠāļĩāļ—āļ”āļĨāļ­āļ‡āđāļšāļšāđ„āļĢāđ‰āļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡

āđ€āļ›āļīāļ”āļšāļąāļāļŠāļĩ āļĨāļ­āļ‡āļšāļąāļāļŠāļĩāđ€āļ”āđ‚āļĄāđˆ āļ”āļēāļ§āļ™āđŒāđ‚āļŦāļĨāļ”āđāļ­āļ›āļĄāļ·āļ­āļ–āļ·āļ­ āļ”āļēāļ§āļ™āđŒāđ‚āļŦāļĨāļ”āđāļ­āļ›āļĄāļ·āļ­āļ–āļ·āļ­
  • The negative currency effect from the sale of the company's Brazil unit and the cyberattack weakened earnings per share by US$1.53 (US$0.74 due to the cyberattack and expected from US$1.15 - US$1.35 for the full year horizon). MCR was 84.3% compared to 83.8% expected on Wall Street, indicating a continuing problem with achieving full profitability.
  • Pharmaceutical services sales and consulting at the Optum unit (103m customers) were $61.1bn vs $54.1bn in Q1 .2023. Medical services sales offered at UnitedHealthCare were $75.3bn vs $70.5bn in Q1 .2023, the company indicated, driven by healthy private client growth (up 2m in Q1 .2024). The company expects adjusted earnings per share of US$27.5 to US$28 in 2024.

United Health (UNH.US) chart, D1 interval

 

Source: xStation5

Johnson&Johnson's adjusted EPS came in at US$2.71 against US$2.65, and sales of US$21.38bn came in marginally lower than the US$21.39bn forecast. Medical technology sales came in at US$7.82bn against US$7.94bn expectations, and the company's full-year sales estimates are now oscillating between US$88bn and US$88.4bn, indicating that the company expects a slight improvement in revenue, in future quarters. The company's shares are trading flat ahead of the US market open.

Johnson&Johnson (JNJ.US) chart, D1 interval

Source: xStation5

āļŦāļļāđ‰āļ™:
āļāļĨāļąāļšāđ„āļ›

āļ‚āđˆāļēāļ§āđƒāļ™āļ•āļĨāļēāļ”āļāļēāļĢāđ€āļ‡āļīāļ™

28.08.2025
08:55

āļ‚āđˆāļēāļ§āđ€āļ”āđˆāļ™āļ§āļąāļ™āļ™āļĩāđ‰: āļŦāļĨāļąāļ‡ NVIDIA āđ‚āļĨāļāļ•āļĨāļēāļ”āļŦāļļāđ‰āļ™āļˆāļ°āđ€āļ›āļĨāļĩāđˆāļĒāļ™āđ„āļ›āļ­āļĒāđˆāļēāļ‡āđ„āļĢ?

āļŠāļĢāļļāļ›āļ•āļĨāļēāļ”āļ›āļĢāļ°āļˆāļģāļ§āļąāļ™āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļāļąāļš NVIDIA āđāļĨāļ°āļ‚āđˆāļēāļ§āđ€āļĻāļĢāļĐāļāļāļīāļˆāđ‚āļĨāļ āļāđˆāļ­āļ™āļ›āļĢāļ°āļāļēāļĻāļœāļĨ NVIDIA: S&P 500 futures +0.1% āļŦāļļāđ‰āļ™ NVIDIA āđƒāļāļĨāđ‰āļˆāļļāļ”āļŠāļđāļ‡āļŠāļļāļ”āļ•āļĨāļ­āļ”āļāļēāļĨ...

08:53

🔝 US500 āļ›āļĢāļąāļšāļ‚āļķāđ‰āļ™āđƒāļāļĨāđ‰ ATH āļŦāļĨāļąāļ‡ Nvidia āļ›āļĢāļ°āļāļēāļĻāļœāļĨāļ›āļĢāļ°āļāļ­āļšāļāļēāļĢ

S&P 500 Futures +0.1% āļ‚āļ“āļ°āļĢāļ­āļœāļĨāļ›āļĢāļ°āļāļ­āļšāļāļēāļĢ Nvidia āđāļĄāđ‰āļāļēāļĢāļ›āļĢāļąāļšāļ‚āļķāđ‰āļ™āļ‚āļ­āļ‡ US500 āļˆāļ°āđ€āļĨāđ‡āļāļ™āđ‰āļ­āļĒ āđāļ•āđˆāļ”āļąāļŠāļ™āļĩ āđƒāļāļĨāđ‰āļˆāļļāļ”āļŠāļđāļ‡āļŠāļļāļ”āļ•āļĨāļ­āļ”āļāļēāļĨ āđāļĨāļ°āļĄāļĩāđ‚āļ­āļāļēāļŠāļ—āļģ Close āļŠāļđāļ‡āļŠāļļāļ”āđ€āļ›āđ‡āļ™āļ›āļĢāļ°āļ§āļąāļ•āļīāļāļēāļĢāļ“āđŒ āļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”āļ‚āļ­āļ‡...

08:49

āļœāļĨāļ›āļĢāļ°āļāļ­āļšāļāļēāļĢāđ„āļ•āļĢāļĄāļēāļŠ NVIDIA: āļĒāļąāļāļĐāđŒ AI āļˆāļ°āļŠāđ‡āļ­āļāļ•āļĨāļēāļ”āļ­āļĩāļāļ„āļĢāļąāđ‰āļ‡?

āļŦāļĨāļąāļ‡āļ•āļĨāļēāļ”āļ›āļīāļ” Nvidia (NVDA.US) āļĢāļēāļĒāļ‡āļēāļ™āļœāļĨāļ›āļĢāļ°āļāļ­āļšāļāļēāļĢāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™ āļŦāļĨāļąāļ‡āļˆāļēāļāļ—āļĩāđˆāļŦāļļāđ‰āļ™āļ›āļĢāļąāļšāļ•āļąāļ§āļ‚āļķāđ‰āļ™āļ­āļĒāđˆāļēāļ‡āđāļ‚āđ‡āļ‡āđāļāļĢāđˆāļ‡āđƒāļ™āļŠāđˆāļ§āļ‡āļŦāļĨāļēāļĒāđ€āļ”āļ·āļ­āļ™āļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļšāļĢāļīāļĐāļąāļ—āļĒāļąāļ‡āļ„āļ‡āđƒāļāļĨāđ‰āļˆāļļāļ”āļŠāļđāļ‡āļŠāļļāļ”āļ›āļĢāļ°āļ§āļąāļ•āļīāļĻāļēāļŠāļ•āļĢāđŒ...

āđ€āļ‚āđ‰āļēāļŠāļđāđˆāļ•āļĨāļēāļ”āļžāļĢāđ‰āļ­āļĄāļĨāļđāļāļ„āđ‰āļēāļ‚āļ­āļ‡ XTB Group āļāļ§āđˆāļē 1 700 000 āļĢāļēāļĒ

āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ—āļĩāđˆāđ€āļĢāļēāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļĄāļĩāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡ āđ€āļĻāļĐāļŦāļļāđ‰āļ™ (Fractional Shares) āđ€āļ›āđ‡āļ™āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļĩāđˆāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļˆāļēāļ XTB āđāļŠāļ”āļ‡āļ–āļķāļ‡āļāļēāļĢāđ€āļ›āđ‡āļ™āđ€āļˆāđ‰āļēāļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļšāļēāļ‡āļŠāđˆāļ§āļ™āļŦāļĢāļ·āļ­ ETF āđ€āļĻāļĐāļŦāļļāđ‰āļ™āđ„āļĄāđˆāđƒāļŠāđˆāļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ­āļīāļŠāļĢāļ° āļŠāļīāļ—āļ˜āļīāļ‚āļ­āļ‡āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ­āļēāļˆāļ–āļđāļāļˆāļģāļāļąāļ”
āļ„āļ§āļēāļĄāļŠāļđāļāđ€āļŠāļĩāļĒāļŠāļēāļĄāļēāļĢāļ–āđ€āļāļīāļ™āļāļ§āđˆāļēāđ€āļ‡āļīāļ™āļ—āļĩāđˆāļāļēāļ